Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis—Brief Report

OBJECTIVE—AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting enzyme) to produce Ang II (angiotensin II). In this study, we determined how these renin-angiotensin components interact with megalin in kidne...

Full description

Saved in:
Bibliographic Details
Published inArteriosclerosis, thrombosis, and vascular biology Vol. 39; no. 2; pp. 150 - 155
Main Authors Ye, Feiming, Wang, Ya, Wu, Congqing, Howatt, Deborah A., Wu, Chia-Hua, Balakrishnan, Anju, Mullick, Adam E., Graham, Mark J., Danser, A.H. Jan, Wang, Jian’an, Daugherty, Alan, Lu, Hong S.
Format Journal Article
LanguageEnglish
Published United States American Heart Association, Inc 01.02.2019
Subjects
Online AccessGet full text
ISSN1079-5642
1524-4636
1524-4636
DOI10.1161/ATVBAHA.118.311817

Cover

Abstract OBJECTIVE—AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting enzyme) to produce Ang II (angiotensin II). In this study, we determined how these renin-angiotensin components interact with megalin in kidney to promote atherosclerosis. APPROACH AND RESULTS—AGT, renin, ACE, and megalin were present in the renal proximal convoluted tubules of wild-type mice. Hepatocyte-specific AGT deficiency abolished AGT protein accumulation in proximal tubules and diminished Ang II concentrations in kidney, while renin was increased. Megalin was most abundant in kidney and exclusively present on the apical side of proximal tubules. Inhibition of megalin by antisense oligonucleotides (ASOs) led to ablation of AGT and renin proteins in proximal tubules, while leading to striking increases of urine AGT and renin concentrations, and 70% reduction of renal Ang II concentrations. However, plasma Ang II concentrations were unaffected. To determine whether AGT and megalin interaction contributes to atherosclerosis, we used both male and female low-density lipoprotein receptor mice fed a saturated fat-enriched diet and administered vehicles (PBS or control ASO) or megalin ASO. Inhibition of megalin did not affect plasma cholesterol concentrations, but profoundly reduced atherosclerotic lesion size in both male and female mice. CONCLUSIONS—These results reveal a regulatory role of megalin in the intrarenal renin-angiotensin homeostasis and atherogenesis, positing renal Ang II to be an important contributor to atherosclerosis that is mediated through AGT and megalin interactions.
AbstractList Objective- AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting enzyme) to produce Ang II (angiotensin II). In this study, we determined how these renin-angiotensin components interact with megalin in kidney to promote atherosclerosis. Approach and Results- AGT, renin, ACE, and megalin were present in the renal proximal convoluted tubules of wild-type mice. Hepatocyte-specific AGT deficiency abolished AGT protein accumulation in proximal tubules and diminished Ang II concentrations in kidney, while renin was increased. Megalin was most abundant in kidney and exclusively present on the apical side of proximal tubules. Inhibition of megalin by antisense oligonucleotides (ASOs) led to ablation of AGT and renin proteins in proximal tubules, while leading to striking increases of urine AGT and renin concentrations, and 70% reduction of renal Ang II concentrations. However, plasma Ang II concentrations were unaffected. To determine whether AGT and megalin interaction contributes to atherosclerosis, we used both male and female low-density lipoprotein receptor-/- mice fed a saturated fat-enriched diet and administered vehicles (PBS or control ASO) or megalin ASO. Inhibition of megalin did not affect plasma cholesterol concentrations, but profoundly reduced atherosclerotic lesion size in both male and female mice. Conclusions- These results reveal a regulatory role of megalin in the intrarenal renin-angiotensin homeostasis and atherogenesis, positing renal Ang II to be an important contributor to atherosclerosis that is mediated through AGT and megalin interactions.Objective- AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting enzyme) to produce Ang II (angiotensin II). In this study, we determined how these renin-angiotensin components interact with megalin in kidney to promote atherosclerosis. Approach and Results- AGT, renin, ACE, and megalin were present in the renal proximal convoluted tubules of wild-type mice. Hepatocyte-specific AGT deficiency abolished AGT protein accumulation in proximal tubules and diminished Ang II concentrations in kidney, while renin was increased. Megalin was most abundant in kidney and exclusively present on the apical side of proximal tubules. Inhibition of megalin by antisense oligonucleotides (ASOs) led to ablation of AGT and renin proteins in proximal tubules, while leading to striking increases of urine AGT and renin concentrations, and 70% reduction of renal Ang II concentrations. However, plasma Ang II concentrations were unaffected. To determine whether AGT and megalin interaction contributes to atherosclerosis, we used both male and female low-density lipoprotein receptor-/- mice fed a saturated fat-enriched diet and administered vehicles (PBS or control ASO) or megalin ASO. Inhibition of megalin did not affect plasma cholesterol concentrations, but profoundly reduced atherosclerotic lesion size in both male and female mice. Conclusions- These results reveal a regulatory role of megalin in the intrarenal renin-angiotensin homeostasis and atherogenesis, positing renal Ang II to be an important contributor to atherosclerosis that is mediated through AGT and megalin interactions.
Objective- AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting enzyme) to produce Ang II (angiotensin II). In this study, we determined how these renin-angiotensin components interact with megalin in kidney to promote atherosclerosis. Approach and Results- AGT, renin, ACE, and megalin were present in the renal proximal convoluted tubules of wild-type mice. Hepatocyte-specific AGT deficiency abolished AGT protein accumulation in proximal tubules and diminished Ang II concentrations in kidney, while renin was increased. Megalin was most abundant in kidney and exclusively present on the apical side of proximal tubules. Inhibition of megalin by antisense oligonucleotides (ASOs) led to ablation of AGT and renin proteins in proximal tubules, while leading to striking increases of urine AGT and renin concentrations, and 70% reduction of renal Ang II concentrations. However, plasma Ang II concentrations were unaffected. To determine whether AGT and megalin interaction contributes to atherosclerosis, we used both male and female low-density lipoprotein receptor mice fed a saturated fat-enriched diet and administered vehicles (PBS or control ASO) or megalin ASO. Inhibition of megalin did not affect plasma cholesterol concentrations, but profoundly reduced atherosclerotic lesion size in both male and female mice. Conclusions- These results reveal a regulatory role of megalin in the intrarenal renin-angiotensin homeostasis and atherogenesis, positing renal Ang II to be an important contributor to atherosclerosis that is mediated through AGT and megalin interactions.
OBJECTIVE—AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting enzyme) to produce Ang II (angiotensin II). In this study, we determined how these renin-angiotensin components interact with megalin in kidney to promote atherosclerosis. APPROACH AND RESULTS—AGT, renin, ACE, and megalin were present in the renal proximal convoluted tubules of wild-type mice. Hepatocyte-specific AGT deficiency abolished AGT protein accumulation in proximal tubules and diminished Ang II concentrations in kidney, while renin was increased. Megalin was most abundant in kidney and exclusively present on the apical side of proximal tubules. Inhibition of megalin by antisense oligonucleotides (ASOs) led to ablation of AGT and renin proteins in proximal tubules, while leading to striking increases of urine AGT and renin concentrations, and 70% reduction of renal Ang II concentrations. However, plasma Ang II concentrations were unaffected. To determine whether AGT and megalin interaction contributes to atherosclerosis, we used both male and female low-density lipoprotein receptor mice fed a saturated fat-enriched diet and administered vehicles (PBS or control ASO) or megalin ASO. Inhibition of megalin did not affect plasma cholesterol concentrations, but profoundly reduced atherosclerotic lesion size in both male and female mice. CONCLUSIONS—These results reveal a regulatory role of megalin in the intrarenal renin-angiotensin homeostasis and atherogenesis, positing renal Ang II to be an important contributor to atherosclerosis that is mediated through AGT and megalin interactions.
Author Wu, Congqing
Howatt, Deborah A.
Ye, Feiming
Wu, Chia-Hua
Balakrishnan, Anju
Graham, Mark J.
Mullick, Adam E.
Wang, Ya
Danser, A.H. Jan
Lu, Hong S.
Daugherty, Alan
Wang, Jian’an
Author_xml – sequence: 1
  givenname: Feiming
  surname: Ye
  fullname: Ye, Feiming
– sequence: 2
  givenname: Ya
  surname: Wang
  fullname: Wang, Ya
– sequence: 3
  givenname: Congqing
  surname: Wu
  fullname: Wu, Congqing
– sequence: 4
  givenname: Deborah
  surname: Howatt
  middlename: A.
  fullname: Howatt, Deborah A.
– sequence: 5
  givenname: Chia-Hua
  surname: Wu
  fullname: Wu, Chia-Hua
– sequence: 6
  givenname: Anju
  surname: Balakrishnan
  fullname: Balakrishnan, Anju
– sequence: 7
  givenname: Adam
  surname: Mullick
  middlename: E.
  fullname: Mullick, Adam E.
– sequence: 8
  givenname: Mark
  surname: Graham
  middlename: J.
  fullname: Graham, Mark J.
– sequence: 9
  givenname: A.H.
  surname: Danser
  middlename: Jan
  fullname: Danser, A.H. Jan
– sequence: 10
  givenname: Jian’an
  surname: Wang
  fullname: Wang, Jian’an
– sequence: 11
  givenname: Alan
  surname: Daugherty
  fullname: Daugherty, Alan
– sequence: 12
  givenname: Hong
  surname: Lu
  middlename: S.
  fullname: Lu, Hong S.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30567480$$D View this record in MEDLINE/PubMed
BookMark eNp9kctuFDEQRa0oiDzgB7JAvWTTiV_tx7IzIiRSIiSUsLU87uoZQ4892G5F7PIRfCFfgkcz2bBg4XJd6d6S6tQZOg4xAEIXBF8SIshV__jtur_tq1CXrBYij9Ap6ShvuWDiuPZY6rYTnJ6gs5y_Y4w5pfgtOmG4E5IrfIqe-rDysUDIPsQVhMaGoXmAlZ18aO5CgWRd8THkZhFDSX45F2hKbPqyhhSzm3bV5z8vv6-Th7H5CtuYyjv0ZrRThveH_xw93Xx6XNy2918-3y36-9bxTsnWSjwIazsNzlGJtcbaDm4gnCi91EKC0g5GNwqt-BJLR5yySgwCFKOsowM7Rx_3c7cp_pwhF7Px2cE02QBxzoaSTjPKleTV-uFgnZcbGMw2-Y1Nv8wrimpQe4OrG-UEo3G-2N3uJVk_GYLNjro5UK9CmT31GqX_RF-n_zfE96HnOFXM-cc0P0Mya7BTWZvdrZjAXUsx0ZhW2daHJfsLhm6WEQ
CitedBy_id crossref_primary_10_1161_ATVBAHA_121_315715
crossref_primary_10_1161_HYPERTENSIONAHA_119_12977
crossref_primary_10_1080_21655979_2021_1960463
crossref_primary_10_1161_ATVBAHA_124_321366
crossref_primary_10_1038_s41581_021_00414_6
crossref_primary_10_1161_HYPERTENSIONAHA_119_12873
crossref_primary_10_1016_j_lfs_2022_120923
crossref_primary_10_3389_fcvm_2023_1250234
crossref_primary_10_1016_j_phrs_2021_105922
crossref_primary_10_1161_HYPERTENSIONAHA_124_22806
crossref_primary_10_1097_MNH_0000000000000586
crossref_primary_10_3389_fendo_2021_738848
crossref_primary_10_1016_j_engreg_2024_06_002
crossref_primary_10_1161_HYPERTENSIONAHA_122_18731
crossref_primary_10_1161_ATVBAHA_124_318374
crossref_primary_10_1002_jcp_29889
crossref_primary_10_1124_pharmrev_120_000236
crossref_primary_10_1161_ATVBAHA_122_318930
crossref_primary_10_1016_j_phrs_2019_104537
crossref_primary_10_1016_j_ooc_2022_100022
crossref_primary_10_1186_s12944_021_01607_5
crossref_primary_10_1161_HYPERTENSIONAHA_119_12703
crossref_primary_10_1016_j_tvjl_2024_106287
crossref_primary_10_1089_jop_2022_0139
crossref_primary_10_1007_s11906_020_01037_1
crossref_primary_10_1016_j_peptides_2021_170714
crossref_primary_10_1016_j_peptides_2022_170770
crossref_primary_10_1161_ATVBAHA_120_313804
crossref_primary_10_1161_HYPERTENSIONAHA_120_14845
crossref_primary_10_1124_pr_118_017129
crossref_primary_10_1161_ATVBAHA_123_319897
crossref_primary_10_1016_j_ejim_2023_06_008
crossref_primary_10_1042_BSR20180201
crossref_primary_10_1007_s12013_024_01555_8
crossref_primary_10_1016_j_neo_2024_101009
crossref_primary_10_1016_j_jacbts_2021_04_004
crossref_primary_10_1159_000526369
crossref_primary_10_1161_JAHA_121_020467
crossref_primary_10_4103_jfmpc_jfmpc_989_24
crossref_primary_10_1016_j_exer_2019_05_020
crossref_primary_10_1016_j_biocel_2023_106393
crossref_primary_10_1111_bph_15955
crossref_primary_10_1161_ATVBAHA_120_314048
crossref_primary_10_3390_ijms22147407
crossref_primary_10_3390_jpm15010003
Cites_doi 10.1126/science.2786251
10.1371/journal.pone.0051483
10.1681/ASN.2011121159
10.7156/v4i4p183
10.1152/ajprenal.00146.2007
10.1161/ATV.0000000000000062
10.1016/j.coph.2011.01.009
10.1016/j.kint.2015.11.007
10.1161/HYPERTENSIONAHA.115.05166
10.1056/NEJM199901143400207
10.1007/BF00583388
10.1681/ASN.2016070734
10.1084/jem.20070120
10.1038/nrm778
10.1038/35025203
10.1152/ajpcell.00287.2006
10.1152/ajpregu.00338.2012
10.1007/BF00537778
10.1161/ATVBAHA.117.309524
10.1074/jbc.275.1.5
10.1161/HYPERTENSIONAHA.115.07012
10.1172/JCI7818
10.1161/01.ATV.0000254680.71485.92
10.1152/ajprenal.00317.2005
10.1007/s11906-006-0040-9
10.1056/NEJMoa0801317
10.1073/pnas.91.21.9725
10.1161/ATVBAHA.107.152363
10.1159/000078716
10.1016/j.ejphar.2015.03.090
10.1172/JCI32970
10.1074/jbc.M110.150284
10.1007/BF01716726
10.1177/1753944715585512
10.1056/NEJM200001203420301
10.1046/j.1523-1755.2002.00155.x
10.1681/ASN.2012010078
10.1007/978-1-59745-571-8_4
10.1161/ATVBAHA.115.307038
10.1161/01.CIR.103.3.448
10.1161/01.HYP.33.1.340
10.1161/ATVBAHA.118.311282
10.1161/ATVBAHA.115.306740
10.1161/01.atv.0000021412.56621.a2
10.1016/S1357-2725(02)00178-4
10.1291/hypres.31.1791
10.1161/atvbaha.113.301777
10.1038/nature06796
10.1083/jcb.131.6.1609
10.1038/hr.2016.17
ContentType Journal Article
Copyright 2019 American Heart Association, Inc.
Copyright_xml – notice: 2019 American Heart Association, Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/ATVBAHA.118.311817
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4636
EndPage 155
ExternalDocumentID 30567480
10_1161_ATVBAHA_118_311817
00043605-201902000-00007
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R01 HL139748
GroupedDBID ---
.3C
.55
.GJ
.Z2
01R
0R~
1J1
23N
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAXQO
ABASU
ABBUW
ABDIG
ABJNI
ABPXF
ABQRW
ABVCZ
ABXVJ
ABZAD
ABZZY
ACCJW
ACDDN
ACEWG
ACGFS
ACGOD
ACILI
ACLDA
ACPRK
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFBFQ
AFDTB
AFFNX
AFUWQ
AGINI
AHJKT
AHMBA
AHOMT
AHQNM
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
AYCSE
BAWUL
BOYCO
BQLVK
BS7
C1A
C45
CS3
DIK
DIWNM
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FRP
FW0
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB2
OCUKA
ODA
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
PZZ
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
V2I
VVN
W3M
W8F
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
ZGI
ZZMQN
AAYXX
ADGHP
CITATION
ACIJW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADKSD
ADSXY
ID FETCH-LOGICAL-c4587-a70d6aa59ecc2709909adcd14189b967e89cefcf6984b07c1c8a86d6e832352d3
ISSN 1079-5642
1524-4636
IngestDate Mon Sep 08 16:45:57 EDT 2025
Thu Apr 03 07:10:00 EDT 2025
Thu Apr 24 23:09:23 EDT 2025
Tue Jul 01 02:22:01 EDT 2025
Fri May 16 03:57:54 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords atherosclerosis
angiotensinogen
angiotensins
mice
renin
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4587-a70d6aa59ecc2709909adcd14189b967e89cefcf6984b07c1c8a86d6e832352d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/6344256
PMID 30567480
PQID 2159324874
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_2159324874
pubmed_primary_30567480
crossref_citationtrail_10_1161_ATVBAHA_118_311817
crossref_primary_10_1161_ATVBAHA_118_311817
wolterskluwer_health_00043605-201902000-00007
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-February
2019-02-00
20190201
PublicationDateYYYYMMDD 2019-02-01
PublicationDate_xml – month: 02
  year: 2019
  text: 2019-February
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Arteriosclerosis, thrombosis, and vascular biology
PublicationTitleAlternate Arterioscler Thromb Vasc Biol
PublicationYear 2019
Publisher American Heart Association, Inc
Publisher_xml – name: American Heart Association, Inc
References e_1_3_5_27_2
e_1_3_5_25_2
e_1_3_5_23_2
e_1_3_5_21_2
e_1_3_5_44_2
e_1_3_5_46_2
e_1_3_5_48_2
e_1_3_5_29_2
e_1_3_5_40_2
e_1_3_5_42_2
e_1_3_5_7_2
e_1_3_5_9_2
e_1_3_5_3_2
e_1_3_5_5_2
e_1_3_5_39_2
e_1_3_5_16_2
e_1_3_5_37_2
e_1_3_5_14_2
e_1_3_5_12_2
e_1_3_5_35_2
e_1_3_5_10_2
e_1_3_5_18_2
e_1_3_5_50_2
e_1_3_5_52_2
e_1_3_5_31_2
Bing J (e_1_3_5_33_2) 1972; 80
e_1_3_5_28_2
e_1_3_5_26_2
e_1_3_5_24_2
e_1_3_5_22_2
e_1_3_5_43_2
e_1_3_5_45_2
e_1_3_5_47_2
e_1_3_5_49_2
e_1_3_5_2_2
e_1_3_5_41_2
e_1_3_5_8_2
e_1_3_5_20_2
e_1_3_5_4_2
e_1_3_5_6_2
e_1_3_5_17_2
e_1_3_5_38_2
e_1_3_5_15_2
e_1_3_5_36_2
e_1_3_5_13_2
e_1_3_5_34_2
e_1_3_5_11_2
e_1_3_5_32_2
e_1_3_5_19_2
e_1_3_5_51_2
e_1_3_5_30_2
References_xml – ident: e_1_3_5_21_2
  doi: 10.1126/science.2786251
– ident: e_1_3_5_44_2
  doi: 10.1371/journal.pone.0051483
– ident: e_1_3_5_20_2
  doi: 10.1681/ASN.2011121159
– ident: e_1_3_5_5_2
  doi: 10.7156/v4i4p183
– ident: e_1_3_5_14_2
  doi: 10.1152/ajprenal.00146.2007
– ident: e_1_3_5_30_2
  doi: 10.1161/ATV.0000000000000062
– ident: e_1_3_5_17_2
  doi: 10.1016/j.coph.2011.01.009
– ident: e_1_3_5_25_2
  doi: 10.1016/j.kint.2015.11.007
– ident: e_1_3_5_27_2
  doi: 10.1161/HYPERTENSIONAHA.115.05166
– ident: e_1_3_5_35_2
  doi: 10.1056/NEJM199901143400207
– ident: e_1_3_5_49_2
  doi: 10.1007/BF00583388
– ident: e_1_3_5_18_2
  doi: 10.1681/ASN.2016070734
– ident: e_1_3_5_34_2
  doi: 10.1084/jem.20070120
– ident: e_1_3_5_23_2
  doi: 10.1038/nrm778
– ident: e_1_3_5_37_2
  doi: 10.1038/35025203
– ident: e_1_3_5_43_2
  doi: 10.1152/ajpcell.00287.2006
– ident: e_1_3_5_16_2
  doi: 10.1152/ajpregu.00338.2012
– ident: e_1_3_5_47_2
  doi: 10.1007/BF00537778
– ident: e_1_3_5_29_2
  doi: 10.1161/ATVBAHA.117.309524
– ident: e_1_3_5_46_2
  doi: 10.1074/jbc.275.1.5
– ident: e_1_3_5_52_2
  doi: 10.1161/HYPERTENSIONAHA.115.07012
– ident: e_1_3_5_9_2
  doi: 10.1172/JCI7818
– ident: e_1_3_5_40_2
  doi: 10.1161/01.ATV.0000254680.71485.92
– ident: e_1_3_5_15_2
  doi: 10.1152/ajprenal.00317.2005
– ident: e_1_3_5_3_2
  doi: 10.1007/s11906-006-0040-9
– ident: e_1_3_5_8_2
  doi: 10.1056/NEJMoa0801317
– ident: e_1_3_5_22_2
  doi: 10.1073/pnas.91.21.9725
– ident: e_1_3_5_42_2
  doi: 10.1161/ATVBAHA.107.152363
– ident: e_1_3_5_13_2
  doi: 10.1159/000078716
– ident: e_1_3_5_4_2
  doi: 10.1016/j.ejphar.2015.03.090
– ident: e_1_3_5_38_2
  doi: 10.1172/JCI32970
– ident: e_1_3_5_26_2
  doi: 10.1074/jbc.M110.150284
– ident: e_1_3_5_48_2
  doi: 10.1007/BF01716726
– ident: e_1_3_5_19_2
  doi: 10.1177/1753944715585512
– ident: e_1_3_5_7_2
  doi: 10.1056/NEJM200001203420301
– ident: e_1_3_5_45_2
  doi: 10.1046/j.1523-1755.2002.00155.x
– ident: e_1_3_5_50_2
  doi: 10.1681/ASN.2012010078
– ident: e_1_3_5_31_2
  doi: 10.1007/978-1-59745-571-8_4
– ident: e_1_3_5_6_2
  doi: 10.1161/ATVBAHA.115.307038
– ident: e_1_3_5_10_2
  doi: 10.1161/01.CIR.103.3.448
– ident: e_1_3_5_51_2
  doi: 10.1161/01.HYP.33.1.340
– ident: e_1_3_5_11_2
  doi: 10.1161/ATVBAHA.118.311282
– ident: e_1_3_5_28_2
  doi: 10.1161/ATVBAHA.115.306740
– volume: 80
  start-page: 646
  year: 1972
  ident: e_1_3_5_33_2
  article-title: Relation between renin substrate and acute phase proteins. Studies of normal and adrenalectomized rats.
  publication-title: Acta Pathol Microbiol Scand A
– ident: e_1_3_5_36_2
  doi: 10.1161/01.atv.0000021412.56621.a2
– ident: e_1_3_5_12_2
  doi: 10.1016/S1357-2725(02)00178-4
– ident: e_1_3_5_41_2
  doi: 10.1291/hypres.31.1791
– ident: e_1_3_5_39_2
  doi: 10.1161/atvbaha.113.301777
– ident: e_1_3_5_2_2
  doi: 10.1038/nature06796
– ident: e_1_3_5_24_2
  doi: 10.1083/jcb.131.6.1609
– ident: e_1_3_5_32_2
  doi: 10.1038/hr.2016.17
SSID ssj0004220
Score 2.4873362
Snippet OBJECTIVE—AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting...
Objective- AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting...
SourceID proquest
pubmed
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 150
SubjectTerms Angiotensin II - biosynthesis
Angiotensinogen - physiology
Animals
Atherosclerosis - etiology
Female
Hypercholesterolemia - complications
Low Density Lipoprotein Receptor-Related Protein-2 - antagonists & inhibitors
Low Density Lipoprotein Receptor-Related Protein-2 - physiology
Male
Mice
Mice, Inbred C57BL
Oligonucleotides, Antisense - pharmacology
Renin-Angiotensin System - physiology
Title Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis—Brief Report
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00043605-201902000-00007
https://www.ncbi.nlm.nih.gov/pubmed/30567480
https://www.proquest.com/docview/2159324874
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3raxQxEA9aobSI-PZ8EcFvkrqPbJL9uBXlECqIV6mflmQ3dxza3da7Q_CvdybJPtqron4Jl93cLOQ3mcwk8yDkpYZdEXZpzkymDOMyE0wrblgqQJPjiZGJwmjkow9ieszfn2Qnw3WBiy5Zm4Pq55VxJf-DKjwDXDFK9h-Q7YnCA_gN-EILCEP7VxgXzWLZOhf0poVB3mnCgsxfhqM-H7XgynL6ylauUEaBSl-7AmLQLlfsEMzleVDFx8pqge6ey2EgwoFlFU5N18MP9r6sIZ_TcArrFGOLZcMWw7m9ly1fht1g485q22ZxPhqH3rz-2ioIxHDmGs4nMCSq9_WwQaYmnGFesrHQ9RmMAnMlIwka-zy025JdoGQvZp8Pi2kBXXWQYsysHA8GdM5OHdZoGEnua0RdyqfdvbpObiQS9C28yP84yjCfJFEXXCXi19sf3CO7HYmLusyWgbJPbv5o0edh9dWFPIwUl9ltcitYHLTw7HOHXLPNXbJ7FHwq7pFPl7iIAqg0cBEdcxEduIiuW3olF1HPRffJ8bu3szdTFkptsIpnsM1oGdVC6yyHFZ1IvCzNdV3VMY9VbnIhrcorO6_mIoeFHMkqrpRWohYWNgRQ4ev0Adlp2sY-IrRW3PK5NpGoQdXmQgugqlIrrAXrI7UTEneTVlYhDz2WQ_lWOntUxGWYc-io0s_5hLzq_3Pms7D8cfSLDosShCXegOnGtptVCfot2Ctgo_MJeehB6ul1oE4Iu4Ba6QOSS3dpDsY_QyaPuowMkXz8W0pPyN6wIJ6SnfX3jX0GKuzaPHc89wso25h1
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Angiotensinogen+and+Megalin+Interactions+Contribute+to+Atherosclerosis-Brief+Report&rft.jtitle=Arteriosclerosis%2C+thrombosis%2C+and+vascular+biology&rft.au=Ye%2C+Feiming&rft.au=Wang%2C+Ya&rft.au=Wu%2C+Congqing&rft.au=Howatt%2C+Deborah+A&rft.date=2019-02-01&rft.eissn=1524-4636&rft.volume=39&rft.issue=2&rft.spage=150&rft_id=info:doi/10.1161%2FATVBAHA.118.311817&rft_id=info%3Apmid%2F30567480&rft.externalDocID=30567480
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1079-5642&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1079-5642&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1079-5642&client=summon